Disarming Germs
From Gizmodo:
Developed by researchers at UCLA and the Geffen School of Medicine, the LpxC-1 antibiotic was developed to fight the drug-resistant Acinetobacter baumannii (pictured above), which commonly attacks hospital patients with open wounds or incisions. By turning off the toxins responsible for inflammation, the drug effectively neutralizes the cells without having to kill them off completely.
Trending Now
55-year-old mom schedules family cruise right before her 30-year-old daughter's grad school graduation, forcing the family to chose which event to attend: 'Many have already said they can't afford both'
01
18-year-old café employee told by her new shift lead to stop talking, stops talking entirely, forcing the lead to backtrack: 'You’re not paid to talk, you’re paid to work'
02
Employee told he is going to lose all of his leave by the end of the year, takes it all at once, leaving projects struggling to be completed: 'Use all your PTO before December 31 or lose it? Alright, don't mind if I do, even if the project burns...'
03
'We paid for your childhood, now it's your turn': Entitled mom expects 26-year-old daughter to pay her bills and cover the cost of flights and hotels for a European family vacation because she paid for her as a kid
04
Your Weekly Caturday Meowgazine: 20 Most Iconic 'I Can Has Meowments' From Silliest to Sincerely Soul-Soothing (June 14, 2025)
05